Prevalence and risks of allosensitization in HeartMate left ventricular assist device recipients: The impact of leukofiltered cellular blood product transfusions

Slides:

Advertisements

Similar presentations

Lost in translation The Journal of Thoracic and Cardiovascular Surgery

Advertisements

Manuel J. Antunes, MD, PhD, DSc

Left ventricular assist devices decrease fixed pulmonary hypertension in cardiac transplant candidates Daniel Zimpfer, MD, Philipp Zrunek, MS, Wilfried.

Stephen R. Broderick, MD, MPHS

The American Association for Thoracic Surgery 2016 Ethics Forum: Cost-effectiveness and the ethics of left ventricular assist device therapy John W.C.

Association of device surface and biomaterials with immunologic sensitization after mechanical support Isaac George, MD, Patrick Colley, BS, Mark J.

Martin Strueber, MD, Anna L

“Lead from the front”: Participative leadership

Left ventricular assist devices decrease fixed pulmonary hypertension in cardiac transplant candidates Daniel Zimpfer, MD, Philipp Zrunek, MS, Wilfried.

Ultrasound, endoscopy, and the recurrent nerve

Factors Influencing HLA Sensitization in Implantable LVAD Recipients

Effects on pre- and posttransplant pulmonary hemodynamics in patients with continuous-flow left ventricular assist devices Ranjit John, MD, Kenneth Liao,

Intrinsic cardiac stem cells are essential for regeneration

Centers for Disease Control “increased-risk” organ donor: Not so risky? Francis D. Pagani, MD, PhD The Journal of Thoracic and Cardiovascular Surgery

Elucidating the intricate mechanisms of gastrointestinal bleeding in a continuous-flow left ventricular assist device will lead to future therapeutic.

Form ever follows function

William M. DeCampli, MD, PhD

Right ventricular failure in patients with the HeartMate II continuous-flow left ventricular assist device: Incidence, risk factors, and effect on outcomes

The lord of the rings Antonio Miceli, MD, PhD

Aldo R. Castañeda, MD, PhD: Recipient of the Lifetime Achievement Award and 74th president of The American Association for Thoracic Surgery Pedro J.

Expanding left ventricular assist device use to patients with disabilities: The role of assistive technology Juan A. Crestanello, MD The Journal of.

Intra-aortic balloon pumps and continuous flow left ventricular assist devices: Don't let balloon pumps overstay their welcome Kevin G. Soucy, PhD, Steven.

Left ventricular assist device therapy in a patient with hearing and speech disabilities Sotirios Spiliopoulos, MD, PhD, Vera Hergesell, MD, Otto Dapunt,

Abdul Rahman Dakkak, MD, Angelo M. Dell'Aquila, MD, Juergen R

Low-Dose Prophylactic Intravenous Immunoglobulin Does Not Prevent HLA Sensitization in Left Ventricular Assist Device Recipients Stavros G. Drakos, MD,

The assessment of cost effectiveness and the effectiveness of cost assessment in cardiothoracic surgery Vinay Badhwar, MD The Journal of Thoracic and.

It's not “just a shunt” but sometimes it should be…

Fixing the supply problem

Do we need a bibliometrician to know which way the wind is blowing?

A first start for lung transplantation?

Right ventricular failure after cardiac surgery: Why can't right ventricular assist device support fix the problem? Francis D. Pagani, MD, PhD The Journal.

Stephen R. Broderick, MD, MPHS

Successful combined procedure of HeartMate II left ventricular assist device implantation and minimally invasive transapical aortic valve replacement

Get it right the first time

William L. Holman, MD, James K. Kirklin, MD, David C

Joseph A. Dearani, MD, Michael J. Ackerman, MD, PhD

Minimally invasive off-pump implantation of HeartMate 3 left ventricular assist device Diyar Saeed, MD, PhD, Stephan Sixt, MD, PhD, Alexander Albert,

Fenton H. McCarthy, MD, MS, Nimesh D. Desai, MD, PhD

Leora B. Balsam, MD, Abe DeAnda, MD

The Ross procedure: Time to reevaluate the guidelines

Video-assisted resection for lung cancer results in fewer complications Lunxu Liu, PhD, MD, FRCS The Journal of Thoracic and Cardiovascular Surgery

Commentary: Bioprosthetic aortic valve replacement: A high standard of comparison for transcatheter aortic valve implantation Aaron Martin, MD, Michael.

Passing the torch The Journal of Thoracic and Cardiovascular Surgery

Impact of antibodies against human leukocyte antigens on long-term outcome in pediatric heart transplant patients: An analysis of the United Network for.

Shunt right or left? Decision 2016

Left ventricular assist device implantation after acute anterior wall myocardial infarction and cardiogenic shock: A two-center study Nicholas C. Dang,

How much does early fundoplication for lung transplant recipients with gastroesophageal reflux disease truly help? Challenges in escaping the perils of.

Jeffrey H. Shuhaiber, MD, Jeff Moore, MS, David B. Dyke, MD

The Journal of Thoracic and Cardiovascular Surgery

Discussion The Journal of Thoracic and Cardiovascular Surgery

The future of cardiac surgery training: A survival guide

Ventricular assistant in restrictive cardiomyopathy: Making the right connection Robert D.B. Jaquiss, MD The Journal of Thoracic and Cardiovascular Surgery

Hope should not spring eternal

Postcardiac transplant survival in the current era in patients receiving continuous-flow left ventricular assist devices Forum Kamdar, MD, Ranjit John,

The Journal of Thoracic and Cardiovascular Surgery

Cerebrovascular accidents in patients with a ventricular assist device

James W. Long, MD, PhD, Aaron H. Healy, BS, Brad Y

Optimal timing of cardiac transplantation after ventricular assist device implantation James S Gammie, MD, Leah B Edwards, PhD, Bartley P Griffith, MD,

Seeing is believing: A call for routine early postoperative hemodynamic transesophageal echocardiography monitoring after left ventricular assist device.

Multivariate Predictors of Heart Transplantation Outcomes in the Era of Chronic Mechanical Circulatory Support Stavros G. Drakos, MD, PhD, Abdallah G.

The Journal of Thoracic and Cardiovascular Surgery

“The more things change…”: The challenges ahead

Optimal timing for heart transplantation in patients bridged with left ventricular assist devices: Is timing of the essence? Chase R. Brown, MD, Fabliha.

Ryan R. Davies, MD The Journal of Thoracic and Cardiovascular Surgery

Proactive or reactive? Best approach to limb ischemia in peripheral venoarterial extracorporeal life support Matthew C. Black, MD, Mark S. Slaughter,

Of mice and men… The Journal of Thoracic and Cardiovascular Surgery

Gastrointestinal bleeding after left ventricular assist device implantation: It is all about the platelets Juan A. Crestanello, MD The Journal of Thoracic.

Did you like Terminator 3 better than Terminator 2

A good chimney requires a good sweep

Journal changes and initiatives

Presentation transcript:

Prevalence and risks of allosensitization in HeartMate left ventricular assist device recipients: The impact of leukofiltered cellular blood product transfusions Stavros G. Drakos, MD, James C. Stringham, MD, James W. Long, MD, PhD, Edward M. Gilbert, MD, Thomas C. Fuller, PhD, Beverly K. Campbell, RN, Benjamin D. Horne, PhD, MPH, Mary E. Hagan, FNP, Karl E. Nelson, RN, Judy M. Lindblom, MT, Patty A. Meldrum, RN, Joanne F. Carlson, MS, NP, Stephanie A. Moore, MD, Abdallah G. Kfoury, MD, Dale G. Renlund, MD The Journal of Thoracic and Cardiovascular Surgery Volume 133, Issue 6, Pages 1612-1619 (June 2007) DOI: 10.1016/j.jtcvs.2006.11.062 Copyright © 2007 The American Association for Thoracic Surgery Terms and Conditions

Figure 1 Time course of development of sensitization (panel reactive antibody [PRA] >10%) after left ventricular assist device (LVAD) implantation. The Journal of Thoracic and Cardiovascular Surgery 2007 133, 1612-1619DOI: (10.1016/j.jtcvs.2006.11.062) Copyright © 2007 The American Association for Thoracic Surgery Terms and Conditions

Figure 2 Kaplan–Meier analysis of incidence of sensitization among left ventricular assist device (LVAD) recipients who either did or did not receive cellular blood product transfusions. The Journal of Thoracic and Cardiovascular Surgery 2007 133, 1612-1619DOI: (10.1016/j.jtcvs.2006.11.062) Copyright © 2007 The American Association for Thoracic Surgery Terms and Conditions

Figure 3 Kaplan–Meier analysis of incidence of transplantation among left ventricular assist device (LVAD) recipients who either did or did not receive cellular blood product transfusions. The Journal of Thoracic and Cardiovascular Surgery 2007 133, 1612-1619DOI: (10.1016/j.jtcvs.2006.11.062) Copyright © 2007 The American Association for Thoracic Surgery Terms and Conditions

Figure 4 Kaplan–Meier analysis of rates of transplantation in left ventricular assist device recipients who either did (panel reactive antibody > 10%) or did not acquire allosensitization. The Journal of Thoracic and Cardiovascular Surgery 2007 133, 1612-1619DOI: (10.1016/j.jtcvs.2006.11.062) Copyright © 2007 The American Association for Thoracic Surgery Terms and Conditions